Lupus miliaris disseminatus faciei with extrafacial involvement in a 17-year-old white girl.
BACKGROUND
Lupus miliaris disseminatus faciei (LMDF) is a benign condition characterized by a papular eruption located in the central face. Histologic studies of the papules show granulomatous infiltrates with central necrosis. The condition is self-limited and usually resolves within 1 to 2 years yet can be cosmetically debilitating, given the location and potential for scarring. Granulomatous periorificial dermatitis similarly affects the face with granulomatous lesions and may overlap clinically with LMDF.


CONCLUSIONS
This report highlights the challenge in differentiating and treating uncommon granulomatous facial dermatoses.
Department of Dermatology, McGill University Health Centre, Montreal, QC, Canada.
Erin
E
Mullan
Peter
P
Green
Sylvia
S
Pasternak
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005148:Facial Dermatoses / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006099:Granuloma / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008177:Lupus Vulgaris / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008795:Metronidazole / Q000627:therapeutic use; D008911:Minocycline / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012393:Rosacea / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D005938:Glucocorticoids; D008795:Metronidazole; D008911:Minocycline; D011241:Prednisone